Companies: 10,795·Total market cap: $144.5T
Ampio Pharmaceuticals, Inc.

Ampio Pharmaceuticals, Inc.

AMPEOTCHealthcare● Active
$0.18
+$0.00(+0.00%)
Market Cap$207884
P/E Ratio
52W High$0.6435
52W Low$0.0001
Overview

Ampio Pharmaceuticals, Inc. (AMPE) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · AMPE · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-11.10ampe eps ttm · ampe earnings per shareEarnings history
PE Ratio (TTM)ampe pe ratio ttm · ampe price to earningsPE Ratio deep dive
Revenue (TTM)245000.00ampe revenue ttm · ampe annual revenueFull revenue history
Dividend YieldNo Dividenddoes ampe pay dividends · ampe dividend yieldDividend history
Shares Outstanding809,000ampe shares outstanding · ampe floatShares outstanding history
Next EarningsAug 11, 2026Est.ampe earnings date · ampe next earningsEarnings history

Financial Snapshot

Full Financials
FY 2023Revenue$0.00
202120222023
ampio pharmaceuticals, inc. revenue · ampe revenue 2023
FY 2023Net Income-$8.6M▲ +47.16% YoY
202120222023
ampio pharmaceuticals, inc. net income · ampe profit 2023
FY 2023EPS$-10.67▲ +5.07% YoY
202120222023
ampe eps · ampio pharmaceuticals, inc. earnings per share 2023
TTM:Revenue: $245000.00Net Income: -$8.6MEPS: $-11.10View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy2 analystsis ampe a buy · ampe analyst rating
Strong Buy
0
Buy
1
Hold
1
Sell
0
Strong Sell
0
12-Month Price Target
$Low
$0.18Current
$Avg Target
$High
ampe price target · ampe 12 month forecast

Total: 2 · Buy rate: 50.0%

Stock Performance

Full History
1D+0.00%
1W+0.00%
1M+0.00%
3M-37.41%
YTD+3421.15%
1Y+40.36%
5Y-99.97%

About Ampio Pharmaceuticals, Inc.

CEOMichael A. Martino
IPO DateMar 31, 2010
Employees6
CountryUS

Ampio Pharmaceuticals, Inc. a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipel…

what is ampio pharmaceuticals, inc. · ampe stock overview · ampio pharmaceuticals, inc. company profile · who is ampio pharmaceuticals, inc. ceo · ampe OTC · ampio pharmaceuticals, inc. headquarters · ampio pharmaceuticals, inc. business segments

About Stock Overview & Key Data

Ampio Pharmaceuticals, Inc. (AMPE) is a Healthcare company in the Biotechnology industry, listed on OTC since Mar 31, 2010. As of the latest trading session, AMPE stock price is $0.18, with a market capitalization of $207,884. The stock has returned +40.36% over the past 12 months and +3421.15% year-to-date.

According to 2 Wall Street analysts, the consensus rating for Ampio Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2023, Ampio Pharmaceuticals, Inc. reported revenue of — and net income of -$8.6M. For detailed data — including Ampio Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Ampio Pharmaceuticals, Inc. (AMPE) stock price is $0.18. The stock is traded on OTC under the ticker symbol AMPE. The 52-week range is $0.00 – $0.64.

AMPE stock priceAMPE quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice